Propiverine
- Generic Name
- Propiverine
- Brand Names
- Mictoryl
- Drug Type
- Small Molecule
- Chemical Formula
- C23H29NO3
- CAS Number
- 60569-19-9
- Unique Ingredient Identifier
- 468GE2241L
- Background
Propiverine is a widely used antimuscarinic drug with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB) .
...
- Indication
Indicated for symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in patients with overactive bladder (OAB) . Propiverine may also be used in patients with neurogenic bladder as a result of spinal cord injury .
- Associated Conditions
- Urinary Incontinence (UI), Urinary Urgency, Increased frequency of urination
- Associated Therapies
- -
Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis
- Conditions
- Interventions
- First Posted Date
- 2019-02-18
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 40
- Registration Number
- NCT03844581
- Locations
- 🇪🇬
Faculty of physical therapy- Cairo University, Giza, Dokki, Egypt
🇪🇬Al Azhar University, Cairo, Egypt
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Astellas Pharma Singapore Pte. Ltd.
- Target Recruit Count
- 5589
- Registration Number
- NCT03602508
- Locations
- 🇦🇺
Site AU10000, Sydney, Australia
🇰🇷Site KR82001, Seoul, Korea, Republic of
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
- First Posted Date
- 2013-12-31
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Takeda
- Target Recruit Count
- 437
- Registration Number
- NCT02024945
Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2015-07-15
- Target Recruit Count
- 62
- Registration Number
- NCT01942681
- Locations
- 🇯🇵
Shinshu University Hospital, Matsumoto, Nagano, Japan
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
- Conditions
- Interventions
- First Posted Date
- 2012-01-19
- Last Posted Date
- 2012-01-25
- Lead Sponsor
- Lee's Pharmaceutical Limited
- Target Recruit Count
- 324
- Registration Number
- NCT01512004
- Locations
- 🇨🇳
Beijing Chaoyang Hospital, Beijing, China
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder
- Conditions
- Interventions
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2009-05-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 264
- Registration Number
- NCT00903045
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2008-11-21
- Lead Sponsor
- APOGEPHA Arzneimittel GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT00795925
A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring
- Conditions
- Interventions
- First Posted Date
- 2008-03-31
- Last Posted Date
- 2008-03-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 41
- Registration Number
- NCT00646880
- Locations
- 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.